Center for Translational Molecular Medicine (CTMM) Revenue

Research Services • Utrecht, Utrecht, Netherlands • 1-10 Employees

Center for Translational Molecular Medicine (CTMM) revenue & valuation

Annual revenue	$171,110
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Research Services industry and current estimated revenues	$547,552
Total funding	No funding

Key Contact at Center for Translational Molecular Medicine (CTMM)

Heidi Hamers

Managing Director (CEO)

Company overview

Headquarters	Jaarbeursplein 6, Utrecht, 3521 AL, NL
Websites	ctmm.nl lygature.org
NAICS	5417
SIC	2834, 283
Founded	2006
Employees	1-10
Socials

About Center for Translational Molecular Medicine (CTMM)

Lygature: result of the merger between CTMM and TI Pharma Since January 1 2016, CTMM (Center for Translational Molecular Medicine) and TI Pharma (Top Institute Pharma) are fully integrated into the new organization Lygature. Lygature was created to help preserve the expertise built up over many years, and to support new initiatives, including any arising from the Dutch government. Lygature is a not-for-profit organization, which drives the development of new medical solutions for patients by managing public-private partnerships involving academia, industry and society. Every day, Lygature brings together people in many different disciplines and organizations – to pioneer solutions in medical technology and pharmacotherapy, and to serve patients worldwide.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Employees by Department

Center for Translational Molecular Medicine (CTMM) has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Center for Translational Molecular Medicine (CTMM) has never raised funding before.

Frequently asked questions

Center for Translational Molecular Medicine (CTMM) is located in Utrecht, Utrecht, NL.

Center for Translational Molecular Medicine (CTMM) generates an estimated annual revenue of $171,110. This revenue figure reflects the company's market position and business performance in its industry.

Center for Translational Molecular Medicine (CTMM) has an estimated valuation of $547,552. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Center for Translational Molecular Medicine (CTMM) was founded in 2006, making it 20 years old. The company has established itself as a significant player in its industry over this time.

Center for Translational Molecular Medicine (CTMM) has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Center for Translational Molecular Medicine (CTMM)

Heidi Hamers

Managing Director (CEO)

4.8

40,000 users